This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A third look: Discussing the potential of Astellas Pharma's VEOZAH (fezolinetant) for vasomotor symptoms (VMS) due to menopause.

Ticker(s): ALPMY

Who's the expert?

Instituion: Yale School of Medicine

  • Obstetrics & Gynecology Specialist and has over 37 years of experience
  • Served as Chairperson of the Obstetrics and Gynecology department at Milford Hospital
  • Founded her current practice seven years ago based on the philosophy of women caring for women.

Interview Goal
.

Do you want answers to these questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.